Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Hinduja Global Solutions gains with arm concluding acquisition of AxisPoint Health

04-Apr2018

Hinduja Global Solutions gains with arm concluding acquisition of AxisPoint Health

Hinduja Global Solutions is currently trading at Rs. 848.70, up by 22.20 points or 2.69% from its previous closing of Rs. 826.50 on the BSE.

The scrip opened at Rs. 844.00 and has touched a high and low of Rs. 857.00 and Rs. 837.75 respectively. So far 2,936 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1042.00 on 08-Feb-2018 and a 52 week low of Rs. 490.65 on 31-Aug-2017.

Last one week high and low of the scrip stood at Rs. 857.00 and Rs. 824.05 respectively. The current market cap of the company is Rs. 1,765.00 crore.

The promoters holding in the company stood at 67.50%, while Institutions and Non-Institutions held 9.54% and 22.97% respectively.

Hinduja Global Solutions' (HGS) subsidiary - HGS Population Health LLC, USA, has completed the acquisition of CMH Services Subsidiary LLC, USA, operating under the trade name of AxisPoint Health, a leading population health management company.

The newly-added portfolio of services opens up an addressable market opportunity of $3 billion for HGS. The acquisition of AxisPoint Health's services will allow HGS to further strengthen its offerings. HGS gains access to over 20 new clients across leading commercial plans, Blues plans and state Medicaid programs.

HGS is a leader in optimizing the customer experience and helping our clients to become more competitive.



Related News

View all news

Reliance Infrastructure trades in green on the bourses

Reliance Infrastructure is currently trading at Rs. 356.00, up by 3.15 points or 0.89% from its previous closing of Rs. 352.85 on the BSE.The scrip opened at Rs. 351.90 and has touched a high and low of......

M&M gains on the BSE

Mahindra & Mahindra is currently trading at Rs. 787.10, up by 6.75 points or 0.86% from its previous closing of Rs. 780.35 on the BSE.The scrip opened at Rs. 782.00 and has touched a high and low......

Alembic Pharma advances on the bourses

Alembic Pharmaceuticals is currently trading at Rs. 571.50, up by 8.90 points or 1.58% from its previous closing of Rs. 562.60 on the BSE.The scrip opened at Rs. 572.95 and has touched a high and low of......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......